
CytoAurora Biotechnologies, Inc. is a biotechnology company founded in 2015, specializing in single-cell technology and applying it to precision medicine. The company integrates semiconductor technology, artificial intelligence, optical systems, molecular pathology, and precision machinery to develop advanced cell detection equipment and AI-powered analysis systems. Their core technology involves semiconductor-based biochips with microfluidic processes for capturing circulating tumor cells. CytoAurora aims to provide more accurate medical services by enabling precise disease prevention and diagnosis, with research and service centers established in several Asian countries. They have developed products like the Cell Reveal Series (CR), CMS (Cyto Multi-staining Scanner), and CA (Cell Aurora), which are applicable in precision medical diagnosis, stem cell/protein drug development, and the CDMO industry. The company's business model appears to be based on the development and sale of their technology and equipment.

CytoAurora Biotechnologies, Inc. is a biotechnology company founded in 2015, specializing in single-cell technology and applying it to precision medicine. The company integrates semiconductor technology, artificial intelligence, optical systems, molecular pathology, and precision machinery to develop advanced cell detection equipment and AI-powered analysis systems. Their core technology involves semiconductor-based biochips with microfluidic processes for capturing circulating tumor cells. CytoAurora aims to provide more accurate medical services by enabling precise disease prevention and diagnosis, with research and service centers established in several Asian countries. They have developed products like the Cell Reveal Series (CR), CMS (Cyto Multi-staining Scanner), and CA (Cell Aurora), which are applicable in precision medical diagnosis, stem cell/protein drug development, and the CDMO industry. The company's business model appears to be based on the development and sale of their technology and equipment.